All News

labs2.jpg

To TDM or Not in Rheumatology?

d Jack Cush, MD

Therapeutic Drug Monitoring (TDM), especially for biologic therapies, has become a standard in gastroenterology, but shunned by most rheumatologists.

Read Article
renal.genes_.jpg

Can SGLT2 Inhibitors Be Protective in Lupus and Vasculitis?

d Jack Cush, MD

SGLT2 inhibitors are all the buzz in the renal world with reports of a renal protective and mortality lowering effects. Maybe these agents should be considered and studied in lupus nephritis and ANCA- associated vasculitis.

Read Article
pain.jpg

Amitriptyline and FDA Treatments for Fibromyalgia

d Jack Cush, MD

Both old and newer pharmacological treatments for fibromyalgia are often promoted; but a recent systematic review and network meta-analysis showed that duloxetine had higher efficacy in pain and depression, while amitriptyline had higher efficacy in treating sleep, fatigue, and quality of life outcomes.

Read Article
RheumNow Podcast square

The Inflammation Reflex (5.20.2022)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. This week, neuroimmunology leading to therapy, the cold shoulder approach and Regulatory updates from the FDA.

Read Article
Medscapes list of Best & Worst States to Practice Best 5: 1) Idaho 2) Georgia 3) S. Dakota 4) Texas 5) Indiana Worst 5: 1)Maine 2)Maryland 3)W.Virginia 4)Rhode Island 5)Wash DC https://t.co/4faJiy9l3D https://t.co/k9WKqo8pah

Links:

Dr. John Cush RheumNow ( View Tweet)
VA and Marketscan data analysis ~345k RA pts shows multimorbidity increased in RA; over-represented are cardiopulmonary, cardiometabolic, and mental health and chronic pain disorders (OR 1.17 - 2.96). https://t.co/awcGQPAdiN https://t.co/c4mLkDzvCM

Links:

Dr. John Cush RheumNow ( View Tweet)
Inflammatory Arthritis Spread by ATP and Neural Crosstalk A novel study suggests that a reflex neural signaling at sites of inflammation may lead to spread to other inflammatory sites via and ATP-mediated neural crosstalk. https://t.co/vaFjqCPKtp https://t.co/RQV6qFh1pw

Links:

Dr. John Cush RheumNow ( View Tweet)
Biologic Persistence in Psoriatic Arthritis and Psoriasis Recent studies examined the durability and persistence of biologic agents in patients with PSO and PsA and while some differences were noted overall persistence was low 3 years later. https://t.co/sqxVaLnXEY https://t.co/yUPWYkRxva

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: Lupus Nephritis: The Blind Men and the Kidney with Dr. Joan Merrill Joan Merrill discusses treatment of lupus nephritis. This was previously recorded at RheumNow Live 2022. https://t.co/IDjOT3Acs0 https://t.co/HkYcoRx5P4

Links:

Dr. John Cush RheumNow ( View Tweet)
Countdown to Step 2, each week I'll be posting one of my favorite doodles from studying! This week- Pulmonary Arterial Hypertension #Meddoodles https://t.co/Hj1i87zZbA
Sarah Lyon sarahthelyon ( View Tweet)
Wiki Guidelines Approach to Pyogenic Osteomyelitis https://t.co/4HD60dbPkk https://t.co/t4xHSWKXys

Links:

Dr. John Cush RheumNow ( View Tweet)
Data from Scleroderma Lung Study (CTX vs MMF in PSS) shows that early progression of ILD by CXR scoring (≥ 2% at 12 or 24 months) experienced significantly worse long-term survival than those with stable Xrays (P = .014). https://t.co/hv2WNJ4Chr https://t.co/W5RIhoIGtT

Links:

Dr. John Cush RheumNow ( View Tweet)
Multimorbidity Burden in Rheumatoid Arthritis Crowson and colleagues at the Mayo Clinic have shown that rheumatoid arthritis (RA) patients have a higher prevalence of multimorbidity with as many as 44 different morbidities of interest in RA. https://t.co/O5U6VXalwa https://t.co/BzXyMGz0ms

Links:

Dr. John Cush RheumNow ( View Tweet)
Many have quoted and shown this image of Ankylosing Spondylitis in a young military recruit at age 25, 35, 45, 50 & 51yrs. This may be the MOST used slide in rheum! It comes from the work of Toronto's Dr. Hugh Little, who sadly passed away at age 58 yrs. https://t.co/e3Zf1OUqtX https://t.co/zOhnQf3ep9

Links:

Dr. John Cush RheumNow ( View Tweet)
Rising Incidence of Systemic Lupus Erythematosus Data from Olmstead county, MN over the past four decades shows that the incidence and prevalence of systemic lupus erythematosus (SLE) is increasing. https://t.co/GUakRwwWQw https://t.co/LPnVMTT8Ro

Links:

Dr. John Cush RheumNow ( View Tweet)
Join us on May 24 at 7pm for Tuesday Night Rheumatology: RA - Best Management We’ll focus on: Drug Cycling Vs Switching in RA Janet Pope, MD, MPH, FRCPC Multimorbidity in RA Elena Myasoedova, MD, PhD Preventing RA Karen Costenbader, MD https://t.co/Vc5uECptIo https://t.co/fu3qACdHkL

Links:

Dr. John Cush RheumNow ( View Tweet)
Watch: The Music of Rheumatology with Dr. Ronan Kavanagh What does music have to do with rheumatology? Quite a lot, actually. https://t.co/R9n0vEYB2J https://t.co/M8Jpg1g6QI

Links:

Dr. John Cush RheumNow ( View Tweet)
Relevance of Raynaud’s in Systemic Sclerosis A recent analysis suggests that RP should be characterized based on color change and the presence of other symptoms to know whether RP portends more serious manifestations. https://t.co/rLo6Ju5LV1 https://t.co/gAQAYxe9rL

Links:

Dr. John Cush RheumNow ( View Tweet)
Israel study of 171 kids w/ MIS-C (med age 8 (5-12): Dx#s - 59 during Alpha , 79 Delta , & 33 Omicron waves. All Rx w/ IVIG + steroids. 6-15% prev recv COVID VAX, none ICU admitted. Worse Dz & higher incidence during alpha wave (54.5/100K) https://t.co/wAby8uKIH4 https://t.co/zc19zeUKpq

Links:

Dr. John Cush RheumNow ( View Tweet)
From 4 Nordic Registries, 24083 RA patients starting 41K courses of bDMARDs shows RA patients had an 80% higher risk of acute coronary syndromes than in the general population. ACS risk on bDMARDs did not improve at 3yrs or 5 yrs https://t.co/TX3jnIXkrW https://t.co/I34UvWH3qd

Links:

Dr. John Cush RheumNow ( View Tweet)

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×